The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10035981 B1

PDF
Full Text
Expired
Date of Patent:
Jul. 31, 2018

Filed:

Jul. 01, 2016
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

Arie Belldegrun, Los Angeles, CA (US);

Cho-Lea Tso, Torrance, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/0783 (2010.01); A61K 39/00 (2006.01); C07K 14/47 (2006.01); C07K 14/535 (2006.01); A61K 9/00 (2006.01); C12N 15/85 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0636 (2013.01); A61K 9/0019 (2013.01); A61K 39/0011 (2013.01); C07K 14/47 (2013.01); C07K 14/4748 (2013.01); C07K 14/535 (2013.01); C12N 15/85 (2013.01); A61K 38/00 (2013.01); A61K 2039/5154 (2013.01); A61K 2039/5158 (2013.01); A61K 2039/53 (2013.01); A61K 2039/54 (2013.01); A61K 2039/55516 (2013.01); A61K 2039/55522 (2013.01); A61K 2039/6031 (2013.01); C12N 2501/22 (2013.01);
Abstract

This invention provides an anti-cancer immunogenic agent(s) (e.g. vaccines) that elicit an immune response specifically directed against renal cell cancers expressing a G250 antigenic marker. Preferred immunogenic agents comprise a chimeric molecule comprising a kidney cancer specific antigen (G250) attached to a granulocyte-macrophage colony stimulating factor (GM-CSF). The agents are useful in a wide variety of treatment modalities including, but not limited to protein vaccination, DNA vaccination, and adoptive immunotherapy.


Find Patent Forward Citations

Belldegrun, Arie. (2018). Kidney-specific tumor vaccine directed against kidney tumor antigen g-250 (U.S. Patent No. 10035981). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10035981

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…